Cargando…
A functional inflammasome activation assaydifferentiates patients with pathogenic NLRP3mutations and symptomatic patients with lowpenetrance variants
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4597079/ http://dx.doi.org/10.1186/1546-0096-13-S1-O74 |
| _version_ | 1782393862367477760 |
|---|---|
| author | Rieber, N Gavrilov, A Hofer, L Singh, A Öz, H Endres, T Schäfer, I Handgretinger, R Hartl, D Kümmerle-Deschner, J |
| author_facet | Rieber, N Gavrilov, A Hofer, L Singh, A Öz, H Endres, T Schäfer, I Handgretinger, R Hartl, D Kümmerle-Deschner, J |
| author_sort | Rieber, N |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4597079 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2015 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-45970792015-10-08 A functional inflammasome activation assaydifferentiates patients with pathogenic NLRP3mutations and symptomatic patients with lowpenetrance variants Rieber, N Gavrilov, A Hofer, L Singh, A Öz, H Endres, T Schäfer, I Handgretinger, R Hartl, D Kümmerle-Deschner, J Pediatr Rheumatol Online J Oral Presentation BioMed Central 2015-09-28 /pmc/articles/PMC4597079/ http://dx.doi.org/10.1186/1546-0096-13-S1-O74 Text en Copyright © 2015 Rieber et al. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
| spellingShingle | Oral Presentation Rieber, N Gavrilov, A Hofer, L Singh, A Öz, H Endres, T Schäfer, I Handgretinger, R Hartl, D Kümmerle-Deschner, J A functional inflammasome activation assaydifferentiates patients with pathogenic NLRP3mutations and symptomatic patients with lowpenetrance variants |
| title | A functional inflammasome activation assaydifferentiates patients with pathogenic NLRP3mutations and symptomatic patients with lowpenetrance variants |
| title_full | A functional inflammasome activation assaydifferentiates patients with pathogenic NLRP3mutations and symptomatic patients with lowpenetrance variants |
| title_fullStr | A functional inflammasome activation assaydifferentiates patients with pathogenic NLRP3mutations and symptomatic patients with lowpenetrance variants |
| title_full_unstemmed | A functional inflammasome activation assaydifferentiates patients with pathogenic NLRP3mutations and symptomatic patients with lowpenetrance variants |
| title_short | A functional inflammasome activation assaydifferentiates patients with pathogenic NLRP3mutations and symptomatic patients with lowpenetrance variants |
| title_sort | functional inflammasome activation assaydifferentiates patients with pathogenic nlrp3mutations and symptomatic patients with lowpenetrance variants |
| topic | Oral Presentation |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4597079/ http://dx.doi.org/10.1186/1546-0096-13-S1-O74 |
| work_keys_str_mv | AT riebern afunctionalinflammasomeactivationassaydifferentiatespatientswithpathogenicnlrp3mutationsandsymptomaticpatientswithlowpenetrancevariants AT gavrilova afunctionalinflammasomeactivationassaydifferentiatespatientswithpathogenicnlrp3mutationsandsymptomaticpatientswithlowpenetrancevariants AT hoferl afunctionalinflammasomeactivationassaydifferentiatespatientswithpathogenicnlrp3mutationsandsymptomaticpatientswithlowpenetrancevariants AT singha afunctionalinflammasomeactivationassaydifferentiatespatientswithpathogenicnlrp3mutationsandsymptomaticpatientswithlowpenetrancevariants AT ozh afunctionalinflammasomeactivationassaydifferentiatespatientswithpathogenicnlrp3mutationsandsymptomaticpatientswithlowpenetrancevariants AT endrest afunctionalinflammasomeactivationassaydifferentiatespatientswithpathogenicnlrp3mutationsandsymptomaticpatientswithlowpenetrancevariants AT schaferi afunctionalinflammasomeactivationassaydifferentiatespatientswithpathogenicnlrp3mutationsandsymptomaticpatientswithlowpenetrancevariants AT handgretingerr afunctionalinflammasomeactivationassaydifferentiatespatientswithpathogenicnlrp3mutationsandsymptomaticpatientswithlowpenetrancevariants AT hartld afunctionalinflammasomeactivationassaydifferentiatespatientswithpathogenicnlrp3mutationsandsymptomaticpatientswithlowpenetrancevariants AT kummerledeschnerj afunctionalinflammasomeactivationassaydifferentiatespatientswithpathogenicnlrp3mutationsandsymptomaticpatientswithlowpenetrancevariants AT riebern functionalinflammasomeactivationassaydifferentiatespatientswithpathogenicnlrp3mutationsandsymptomaticpatientswithlowpenetrancevariants AT gavrilova functionalinflammasomeactivationassaydifferentiatespatientswithpathogenicnlrp3mutationsandsymptomaticpatientswithlowpenetrancevariants AT hoferl functionalinflammasomeactivationassaydifferentiatespatientswithpathogenicnlrp3mutationsandsymptomaticpatientswithlowpenetrancevariants AT singha functionalinflammasomeactivationassaydifferentiatespatientswithpathogenicnlrp3mutationsandsymptomaticpatientswithlowpenetrancevariants AT ozh functionalinflammasomeactivationassaydifferentiatespatientswithpathogenicnlrp3mutationsandsymptomaticpatientswithlowpenetrancevariants AT endrest functionalinflammasomeactivationassaydifferentiatespatientswithpathogenicnlrp3mutationsandsymptomaticpatientswithlowpenetrancevariants AT schaferi functionalinflammasomeactivationassaydifferentiatespatientswithpathogenicnlrp3mutationsandsymptomaticpatientswithlowpenetrancevariants AT handgretingerr functionalinflammasomeactivationassaydifferentiatespatientswithpathogenicnlrp3mutationsandsymptomaticpatientswithlowpenetrancevariants AT hartld functionalinflammasomeactivationassaydifferentiatespatientswithpathogenicnlrp3mutationsandsymptomaticpatientswithlowpenetrancevariants AT kummerledeschnerj functionalinflammasomeactivationassaydifferentiatespatientswithpathogenicnlrp3mutationsandsymptomaticpatientswithlowpenetrancevariants |